王丽华, 李玉芝, 王亮亮, 王蓓蓓, 张競. Ⅱb期宫颈癌术前同步放化疗30例疗效分析[J]. 蚌埠医学院学报, 2013, 37(8): 985-986,989.
    引用本文: 王丽华, 李玉芝, 王亮亮, 王蓓蓓, 张競. Ⅱb期宫颈癌术前同步放化疗30例疗效分析[J]. 蚌埠医学院学报, 2013, 37(8): 985-986,989.
    WANG Li-hua, LI Yu-zhi, WANG Liang-liang, WANG Bei-bei, ZHANG Jing. The curative effect analysis of preoperative concurrent chemoradiotherapy for 30 cases with Ⅱb cervical cancer[J]. Journal of Bengbu Medical College, 2013, 37(8): 985-986,989.
    Citation: WANG Li-hua, LI Yu-zhi, WANG Liang-liang, WANG Bei-bei, ZHANG Jing. The curative effect analysis of preoperative concurrent chemoradiotherapy for 30 cases with Ⅱb cervical cancer[J]. Journal of Bengbu Medical College, 2013, 37(8): 985-986,989.

    Ⅱb期宫颈癌术前同步放化疗30例疗效分析

    The curative effect analysis of preoperative concurrent chemoradiotherapy for 30 cases with Ⅱb cervical cancer

    • 摘要: 目的:探讨Ⅱb期宫颈癌术前同步放化疗近期临床疗效。方法:将58例组织学明确的Ⅱb期宫颈癌患者分为A组28例,术前给予新辅助化疗;B组30例,术前同步放化疗。比较2组的临床疗效、手术时间、术中出血量、膀胱功能恢复等指标。结果:B组近期临床有效率为90. 00%,高于A组的67. 86%(P0. 05);2组手术时间、术中出血量及膀胱功能恢复时间差异均无统计学意义(0. 05);术前放化疗能降低子宫旁浸润和淋巴结转移率(P0. 05)。结论:术前同步放化疗能提高Ⅱb期宫颈癌近期临床疗效,提高手术切除率,减少子宫旁浸润和盆腔淋巴结转移,是一种可选的治疗方法。

       

      Abstract: To explore the curative effects of preoperative concurrent chemoradiotherapy for Ⅱb cervical cancer. Methods:Fifty-eight cases with Ⅱb cervical cancer were divided into group A( 28 cases) and group B( 30 cases) . Group A and B were treated with chemotherapy and concurrent chemoradiotherapy before operation, respectively. The clinical effects,adverse reactions,operative time,blood loss,pathological features and recovery time of bladder function in two groups were analyzed. Results: The clinical effective rate in group B( 90. 00%) was higher than that in group A( 67. 86%) ( P < 0. 05) . The differences of operative time,blood loss and recovery time of bladder function in two groups were not statistical significante( P > 0. 05) . The preoperative chemoradiotherapy could decrease parametrial invasion and pelvic lymphnode metastasis ( P < 0. 05). Conclusions: The preoperative concurrent chemoradiotherapy for Ⅱb cervical cancer can improve the clinical effects and resectable rate and decrease parametrial invasion and pelvic lymphnode metastasis,which is a practicable means.

       

    /

    返回文章
    返回